Short Interest in Fresenius SE & Co. (OTCMKTS:FSNUY) Declines By 63.4%

Fresenius SE & Co. (OTCMKTS:FSNUY) was the target of a large decline in short interest in the month of January. As of January 30th, there was short interest totaling 13,176 shares, a decline of 63.4% from the January 15th total of 35,983 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 89,790 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily trading volume, of 89,790 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the shares of the company are short sold.

Fresenius SE & Co. Price Performance

Shares of OTCMKTS:FSNUY traded down $0.05 during midday trading on Friday, reaching $14.88. 586 shares of the company’s stock traded hands, compared to its average volume of 63,186. The company has a fifty day simple moving average of $14.33 and a two-hundred day simple moving average of $14.19. Fresenius SE & Co. has a 1 year low of $9.54 and a 1 year high of $33.93. The company has a market cap of $33.52 billion, a P/E ratio of 27.05 and a beta of 0.75. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.99 and a current ratio of 1.26.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Fresenius SE & Co. in a research report on Monday, October 27th. Morgan Stanley reaffirmed an “overweight” rating on shares of Fresenius SE & Co. in a report on Monday, December 15th. Finally, Citigroup reiterated a “buy” rating on shares of Fresenius SE & Co. in a research note on Tuesday, February 3rd. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock has an average rating of “Buy”.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.